TerrAscendSTU:TED +3.15%38 Pretax Margin % is 5.22% as of Mar. 2026. GuruFocus rates STU:TED with a GF Score™ of 38/100 and a GF Value™ of €0.85 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 955 Drug Manufacturers companies, TerrAscend ranks worse than 62.72% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. TerrAscend's Pre-Tax Income for the
three
months ended in Mar. 2026 was €3.0 Mil. TerrAscend's Revenue for the
three
months ended in Mar. 2026 was €56.7 Mil. Therefore, TerrAscend's pretax margin for the quarter that ended in Mar. 2026 was 5.22%.
The historical rank and industry rank for TerrAscend's Pretax Margin % or its related term are showing as below:
STU:TED'
s Pretax Margin % Range Over the Past 10 Years
Min: -314.08 Med: -45.06 Max: 22.93
Current: 2.11
STU:TED's Pretax Margin % is ranked worse than 62.72% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs STU:TED: 2.11
TerrAscend (STU:TED) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
TerrAscend Pretax Margin % Related Terms
TerrAscend Pretax Margin % Historical Data
* Premium members only.
The historical data trend for TerrAscend's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, TerrAscend's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TerrAscend Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TerrAscend's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where TerrAscend's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TerrAscend (STU:TED) has a Pretax Margin % of 5.22% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on TerrAscend and its competitors. According to the industry distribution chart, TerrAscend ranks #599 out of 955 companies in the Drug Manufacturers industry, placing it in the top 62.7%.
Is TerrAscend's Pretax Margin % too high?
TerrAscend's current Pretax Margin % is 5.22%. The Drug Manufacturers industry median Pretax Margin % is 7.28. TerrAscend's value of 5.22% is 28.3% below this industry median. Based on the distribution chart, TerrAscend ranks #599 out of 955 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, TerrAscend has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TerrAscend's Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, TerrAscend ranks #599 out of 955 companies for Pretax Margin %. This places TerrAscend in the lower half of its industry. The industry median Pretax Margin % is 7.28. TerrAscend's value of 5.22% is 28.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TerrAscend's current Pretax Margin % of 5.22% is 28.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on TerrAscend and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TerrAscend's current Pretax Margin % is 5.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TerrAscend stock overvalued right now?
Based on GuruFocus' analysis, TerrAscend (STU:TED) is currently considered Possible Value Trap. The stock's GF Value™ is €0.85, compared to a current price of €0.56 — trading 34.5% below its estimated fair value. The current Pretax Margin % is 5.22% and 28.3% below the Drug Manufacturers industry median of 7.28. TerrAscend's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For TerrAscend (STU:TED), the current Pretax Margin % is 5.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TerrAscend (STU:TED) Overvalued in 2026?
Based on GuruFocus' analysis, TerrAscend stock appears to be undervalued.
The current stock price of €0.56 is trading 34.5% below its estimated GF Value™ of €0.85.
GuruFocus considers TerrAscend to be Possible Value Trap.
Key valuation signals for STU:TED:
Pretax Margin %: 5.22%
GF Value™: €0.85 vs. price of €0.56 (34.5% below fair value)
Industry Position: 28.3% below the Drug Manufacturers median (#599 of 955)
No single metric tells the full story. See the STU:TED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.
38GF Score
Get the complete analysis for STU:TED
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:TED has been successfully added to your 
